This work was supported by France Parkinson (NCT02319382) ,
Mechanisms underlying inflammation in neurodegeneration, Cell, vol.140, pp.918-934, 2010. ,
The peripheral benzodiazepine receptor (translocator protein 18kDa) in microglia: from pathology to imaging, Prog Neurobiol, vol.80, pp.308-322, 2006. ,
In vivo imaging of the 18-kDa translocator protein (TSPO) with [ 18 F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients, Eur J Nucl Med Mol Imaging, vol.40, pp.921-931, 2013. ,
Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, 18 F-PBR06, J Nucl Med, vol.50, pp.1047-1053, 2009. ,
Quantification of the specific translocator protein signal of 18 F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding, J Nucl Med, vol.54, pp.1915-1923, 2013. ,
Quantitation of translocator protein binding in human brain with the novel radioligand [ 18 F]-FEPPA and positron emission tomography, J Cereb Blood Flow Metab, vol.31, pp.1807-1816, 2011. ,
in a model of cerebral ischemia in rats, PLoS ONE, vol.8, p.56441, 2013. ,
Comparative evaluation of the translocator protein radioligands 11 C-DPA-713, 18 F-DPA-714, and 11 C-PK11195 in a rat model of acute neuroinflammation, J Nucl Med, vol.50, pp.468-476, 2009. ,
Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging, J Neurosci, vol.32, pp.10809-10818, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-02110993
Initial evaluation in healthy humans of [ 18 F]DPA-714, a potential PET biomarker for neuroinflammation, Nucl Med Biol, vol.39, pp.570-578, 2012. ,
Molecular imaging of microglial activation in amyotrophic lateral sclerosis, PLoS ONE, vol.7, p.52941, 2012. ,
Quantification of [F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients, J Cereb Blood Flow Metab, vol.35, pp.766-772, 2015. ,
Could (18) F-DPA-714 PET imaging be interesting to use in the early post-stroke period?, EJNMMI Res, vol.4, pp.28-35, 2014. ,
Two binding sites for [ 3 H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation, J Cereb Blood Flow Metab, vol.30, pp.1608-1618, 2010. ,
Determination of [ 11 C]PBR28 binding potential in vivo: a first human TSPO blocking study, J Cereb Blood Flow Metab, vol.34, pp.989-994, 2014. ,
Consensus nomenclature for in vivo imaging of reversibly binding radioligands, J Cereb Blood Flow Metab, vol.27, pp.1533-1539, 2007. ,
Initial evaluation of 11 C-DPA-713, a novel TSPO PET ligand, in humans, J Nucl Med, vol.50, pp.1276-1282, 2009. ,
Reference and target region modeling of [ 11 C]-(R)-PK11195 brain studies, J Nucl Med, vol.48, pp.158-167, 2007. ,
Regional brain distribution of translocator protein using [ 11 C]DPA-713 PET in individuals infected with HIV, J Neurovirol, vol.20, pp.219-232, 2014. ,
Mixed-affinity binding in humans with 18-kDa translocator protein ligands, J Nucl Med, vol.52, pp.24-32, 2011. ,
Neuroinflammation in healthy aging: a PET study using a novel translocator protein 18kDa (TSPO) radioligand, Neuroimage, vol.84, pp.868-875, 2014. ,
Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [ 18 F]-FEPPA, J Cereb Blood Flow Metab, vol.32, pp.968-972, 2012. ,
Metabolism and quantification of [ 18 F] DPA-714, a new TSPO positron emission tomography radioligand, Drug Metab Dispos, vol.41, pp.122-131, 2013. ,
,
, J Nucl Med
,
, Information about reproducing figures, tables, or other portions of this article can be found online at